氏名 | |
---|---|
職位 | 准教授 |
所属教室 | |
専攻・専門分野(大学院) |
医学専攻 臨床検査医学分野(新課程) 病理系専攻 臨床検査医学分野(旧課程) |
担当科目(学部) | 臨床検査学、輸血学 |
担当科目(大学院) | 臨床検査医学:食物アレルゲンを用いたナッツアレルギーの病態解明・高精度診断法の確立 |
専門分野 | 臨床検査医学、小児科学、アレルギー学、免疫学 |
研究テーマ | 食物アレルギーの診断法の開発 |
略歴 | 1997年 東京大学医学部附属病院研修医 1998年 東京大学医学部附属病院小児科医員 2000年 亀田総合病院小児科 2005年 東京大学助手医学部小児科助教 2006年 焼津市立総合病院小児科医長 2008年 La Jolla Institute for Allergy and Immunology (Postdoctoral Fellow) 2012年 NTT東日本関東病院小児科 2013年 東京大学医学部小児科助教 2018年 山口大学医学部小児科学講座講師 2020年 成育医療研究センター アレルギーセンター臨床研究員(併任) 2021年 山口大学小児科学講座准教授 2022年 杏林大学臨床検査医学教室准教授 |
所有する学位 | 博士(医学) |
指導医・専門医・認定医、その他の資格等 | 日本小児科学会専門医・指導医 日本アレルギー学会専門医 日本リウマチ学会専門医 |
論文・著書等を含む主要研究業績 |
詳細な業績は researchmap 研究者総覧 をご覧ください
2. Okada S, Yasudo H, et al. Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease. Inflammation. 46:480-490,2023. 3. Kimura S, Yasudo H, et al. Histological characteristics of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in asthmatic murine model during A(H1N1)pdm09 infection. Pathol Int. 72:506-518, 2022. 4. Furuta T, Yasudo H, et al. Third-line therapies in patients with Kawasaki disease refractory to first- and second-line intravenous immunoglobulin therapy. World J Pediatr. 18:781-785, 2022. 5. Ohnishi Y, Okada S, Yasudo H, et al. Safety and Feasibility of Infliximab Therapy in Children With Kawasaki Disease Who Received Live Vaccinations. Pediatr Infect Dis J. 41:e388-e392,2022. 6. Yasudo H, et.al. Pollen Food Allergy Syndrome in Allergic March. Nutrients. 14:2658, 2022. 7. Asano K, Tamari M, Yasudo H, et al. Diversities of allergic pathologies and their modifiers: Report from the second DGAKI-JSA meeting. Allergol Int. 71:310-317, 2022. 8. Yasudo H, et al. Predictive value of 7S globulin-specific IgE in Japanese macadamia nut allergy patients. J Allergy Clin Immunol Pract. 10:1389-1391,2022 9. Yasudo H, et al. A Possible Association Between a Nucleotide-Binding Domain LRR-Containing Protein Family PYD-Containing Protein 1 Mutation and an Autoinflammatory Disease Involving Liver Cirrhosis. Hepatology. 74:2296-2299, 2021 10. Yasudo H, et al. Food allergens detected in indoor pet fur. J Dermatol Sci. 104:213-215, 2021. 11. Yasudo H and Hasegawa S. How could maternal allergies affect preterm outcomes in infancy? Pediatr Int 63: 1005, 2021 12. Morita K, Yasudo H, et al. Seasonal variability of epidermal Bleomycin Hydrolase activity in healthy children and pediatric patients with atopic dermatitis. J Dermatol Sci 102 : 137-139, 2021.(corresponding author) 13. Okazaki F, Wakiguchi H, Yasudo H, et al. A novel mutation in early-onset sarcoidosis/Blau syndrome and first report of an association with Propionibacterium acnes. Pediatric Rheumatology. Pediatr Rheumatol Online J 19:18, 2021. 14. Ariyoshi T, Tezuka J, Yasudo H, et al. Enhanced airway hyperresponsiveness in asthmatic children and mice with A(H1N1)pdm09 infection. Immun Inflamm Dis 9 : 457-465, 2021. (corresponding author) 15. Korenaga Y, Wakiguchi H, Yasudo H, et al. Juvenile NPSLE with MRI findings similar to acute necrotizing encephalopathy. J Clin Rheumatol 27:S625-S626, 2021. 16. Motonaga T, Okada S, Yasudo H, et al. Responses to Treatment According to the Cytokine Profiles of Pericardial Effusion in Two Children with Idiopathic Pericarditis. Int Heart J 61:1307-1310, 2020. 17. Ohnishi Y, Okada S, Yasudo H, et al. Pulmonary Hypertension Following Increased Dosing of Diazoxide in an Infant. Int Heart J 61:1084-1087, 2020.(corresponding author) 18. Furuta T, Yasudo H, et al. The Efficacy and Safety of Infliximab Therapy for Refractory Kawasaki Disease in Infants. Pediatr Infect Dis J 39:e219, 2020. (corresponding author) 19. Hoshide M, Yasudo H, et al. Efficacy of hypothermia therapy in patients with acute encephalopathy with biphasic seizures and late reduced diffusion. Brain Dev 42:515-522, 2020. (corresponding author) 20. Azuma Y, Suzuki Y, et al. Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease. Front Pediatr 8:148, 2020.(corresponding author) 21. Fukuda K, Yasudo H, et al. Time-course Evaluation of Body Mass Index in Japanese Children with Obstructive Sleep Apnea Syndrome After Adenotonsillectomy : A Three-year Follow-up Study. Front Pediatr 8 : 22, 2020.(corresponding author) 22. Sakata Y, Yasudo H, et al. Diagnostic Utility of Ultrasonography for Duodenal Ulcers in Pediatric Cases in Japan. Front Pediatr 7 : 547, 2020. (corresponding author) 23. Iida Y, Yasudo H, et al. Surge of serum interleukin-2 level in a Japanese patient with cytarabine syndrome. Pediatr Blood Cancer 67:e28131, 2020.(corresponding author) 24. Abe N, Yasudo H, et al. Multi-season analyses of causative pathogens in children hospitalized with asthma exacerbation. Pediatr Allergy Immunol. 30: 724-731, 2019. (corresponding author) 25. Ohnishi Y, Yasudo H, et al. Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease. Int J Cardiol 292 : 236-240, 2019. (corresponding author) 26. Ohta N, Yasudo H, et al. Serum soluble ST2 as a marker of renal scar in pediatric upper urinary tract infection. Cytokine 120 : 258-263, 2019. (corresponding author) 27. Iida Y, Wakiguchi H, Yasudo H, et al. Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene. Clin Rheumatol 38 : 943-948, 2019. 28. Akashi M, Yasudo H, et al. Randomized controlled trial of oral immunotherapy for egg allergy in Japanese patients. Pediatr Int 59:534-539, 2017. 29. Hirano Y, Itonaga T, Yasudo H, et al. Systemic lupus erythematosus presenting with mixed-type fulminant autoimmune hemolytic anemia. Pediatr Int 58 : 527-530, 2016. (corresponding author) 30.Yasudo H, et al. Suplatast tosilate for treating cutaneous mastocytosis. Pediatr Dermatol 32 : e118-119, 2015. 31. Yasudo H, et al. Systemic lupus erythematosus complicated with liver cirrhosis in a patient with Papillon-Lefèvre syndrome. Lupus 23: 1523-1527, 2014. 32.Yasudo H, et al. Short Stat5-interacting peptide derived from phospoholipase C-β3 inhibits hematopoietic cell proliferation and myeloid differentiation. PLoS One 6 : e24995, 2011. 33.Xiao W, Kashiwakura J, Yasudo H, et al. Phospholipase C-β3 regulates FcɛRI-mediated mast cell activation by recruiting the protein phosphatase SHP-1.Immunity 34:893-904, 2011. 34. Xiao W, Hong H, Yasudo H, et al. Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5. Cancer Cell 16:161-171, 2009. |
所属学会 |
日本臨床検査医学会 日本アレルギー学会(代議員) 日本小児アレルギー学会(代議員) 日本リウマチ学会 |
学外活動 | 山口大学小児科非常勤講師 |